HK1040192A1 - 生物雌激素氨基磺酸酯在激素替代治療中的應用 - Google Patents

生物雌激素氨基磺酸酯在激素替代治療中的應用

Info

Publication number
HK1040192A1
HK1040192A1 HK02101596.4A HK02101596A HK1040192A1 HK 1040192 A1 HK1040192 A1 HK 1040192A1 HK 02101596 A HK02101596 A HK 02101596A HK 1040192 A1 HK1040192 A1 HK 1040192A1
Authority
HK
Hong Kong
Prior art keywords
replacement therapy
hormone replacement
biogenic estrogen
estrogen sulfamates
sulfamates
Prior art date
Application number
HK02101596.4A
Other languages
English (en)
Inventor
瓦爾特‧埃爾格
佩卡‧萊赫滕邁基
馬蒂‧萊赫蒂寧
古德龍‧雷德爾森
霍爾格‧齊默爾曼
米夏埃爾‧厄特勒
西格弗里德‧施瓦茨
Original Assignee
耶拿制葯兩合公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 耶拿制葯兩合公司 filed Critical 耶拿制葯兩合公司
Publication of HK1040192A1 publication Critical patent/HK1040192A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
HK02101596.4A 1998-07-28 2002-03-01 生物雌激素氨基磺酸酯在激素替代治療中的應用 HK1040192A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19834931A DE19834931A1 (de) 1998-07-28 1998-07-28 Verwendung von biogenen Estrogenen zur Hormonsubstitutionstherapie
PCT/DE1999/001496 WO2000006175A1 (de) 1998-07-28 1999-05-13 Verwendung von biogenen estrogenssulfamaten zur hormonsubstitutionstherapie

Publications (1)

Publication Number Publication Date
HK1040192A1 true HK1040192A1 (zh) 2002-05-31

Family

ID=7876248

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02101596.4A HK1040192A1 (zh) 1998-07-28 2002-03-01 生物雌激素氨基磺酸酯在激素替代治療中的應用

Country Status (28)

Country Link
US (1) US7053077B1 (zh)
EP (1) EP1100509B1 (zh)
JP (1) JP4891479B2 (zh)
KR (1) KR20010072082A (zh)
CN (1) CN1311683A (zh)
AP (1) AP2001002054A0 (zh)
AR (1) AR016502A1 (zh)
AT (1) ATE292468T1 (zh)
AU (1) AU766019B2 (zh)
BG (1) BG105171A (zh)
BR (1) BR9912466A (zh)
CA (1) CA2338558A1 (zh)
CO (1) CO5261567A1 (zh)
DE (2) DE19834931A1 (zh)
EA (1) EA003371B1 (zh)
EE (1) EE200100053A (zh)
HK (1) HK1040192A1 (zh)
HU (1) HUP0102913A3 (zh)
IL (1) IL141081A0 (zh)
IS (1) IS5819A (zh)
MX (1) MXPA01000548A (zh)
NO (1) NO20010468L (zh)
NZ (1) NZ509521A (zh)
PL (1) PL345588A1 (zh)
SK (1) SK1292001A3 (zh)
TR (1) TR200100234T2 (zh)
WO (1) WO2000006175A1 (zh)
ZA (1) ZA200100743B (zh)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004521951A (ja) * 2001-07-13 2004-07-22 シエーリング アクチエンゲゼルシャフト Ｈｒｔのためのドロスピレノン及びエストロゲンスルファメートの組み合わせ
US8026229B2 (en) 2001-08-13 2011-09-27 Sterix Limited Antitumor-active 2-alkoxyestradiol sulfamates
US8282612B1 (en) 2008-03-07 2012-10-09 Denise H. Miller Methods and devices for intrauterine absorption
WO2013078422A2 (en) 2011-11-23 2013-05-30 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
EP2647379A1 (en) * 2012-04-05 2013-10-09 PregLem S.A. Combined use of a steroid sulfatase inhibitor for the treatment of endometriosis
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US9078786B1 (en) 2012-10-19 2015-07-14 Denise H. Miller Methods and devices for collecting body fluids
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5314694A (en) * 1990-10-29 1994-05-24 Alza Corporation Transdermal formulations, methods and devices
WO1995001161A1 (en) * 1993-06-29 1995-01-12 Leiras Oy Pack for use in, and method of hormonal replacement therapy
DE4429397C2 (de) * 1994-08-09 2003-11-20 Jenapharm Gmbh Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE4429398C2 (de) * 1994-08-09 1997-09-11 Jenapharm Gmbh Verwendung von Estra-1,3,5(10)-trien-Derivaten zur hormonalen Kontrazeption
DE4429374C1 (de) 1994-08-12 1996-02-01 Jenapharm Gmbh Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente
DE19610635A1 (de) * 1996-03-11 1997-09-18 Schering Ag Sequentielle Estrogen/Progesteronantagonist-Kombination für die Hormonersatz-Therapie
IL123422A (en) * 1997-03-05 2003-05-29 Akzo Nobel Nv USE OF 7alpha-METHYL-17alpha-ETHYNYL-ESTRANE DERIVATIVES FOR THE MANUFACTURE OF A MEDICAMENT FOR THE PROPHYLAXIS OR THE TREATMENT OF ATHEROSCLEROSIS
AU4957999A (en) * 1998-07-17 2000-02-07 Pharmacia & Upjohn Company Subcutaneous medroxyprogesterone acetate for contraception

Also Published As

Publication number Publication date
BG105171A (bg) 2001-07-31
CO5261567A1 (es) 2003-03-31
US7053077B1 (en) 2006-05-30
PL345588A1 (en) 2001-12-17
DE19834931A1 (de) 2000-02-24
AU766019B2 (en) 2003-10-09
HUP0102913A2 (hu) 2002-01-28
DE59911879D1 (de) 2005-05-12
EE200100053A (et) 2002-06-17
NO20010468L (no) 2001-03-27
WO2000006175A1 (de) 2000-02-10
ATE292468T1 (de) 2005-04-15
SK1292001A3 (en) 2001-07-10
EA200100108A1 (ru) 2001-12-24
EA003371B1 (ru) 2003-04-24
JP2002521452A (ja) 2002-07-16
AU5148199A (en) 2000-02-21
ZA200100743B (en) 2002-05-08
BR9912466A (pt) 2001-04-17
AR016502A1 (es) 2001-07-04
CA2338558A1 (en) 2000-02-10
EP1100509A1 (de) 2001-05-23
EP1100509B1 (de) 2005-04-06
MXPA01000548A (es) 2002-04-08
TR200100234T2 (tr) 2001-06-21
AP2001002054A0 (en) 2001-03-31
IL141081A0 (en) 2002-02-10
NO20010468D0 (no) 2001-01-26
NZ509521A (en) 2003-11-28
CN1311683A (zh) 2001-09-05
HUP0102913A3 (en) 2002-03-28
JP4891479B2 (ja) 2012-03-07
IS5819A (is) 2001-01-19
KR20010072082A (ko) 2001-07-31

Similar Documents

Publication Publication Date Title
PL345588A1 (en) Use of biogenic estrogen sulfamates for hormone replacement therapy
HUP0204291A3 (en) Use of composition containing estrogen and drospirenone for hormone replacement therapy
HUP0200416A3 (en) Pharmaceutical composition useful for low dose estrogen interrupted hormone replacement therapy
IL138129A0 (en) Therapy of estrogen associated disorders
GB2320190B (en) Total hormone replacement therapy
HRP20020837A2 (en) Hormone replacement therapy
IL141553A0 (en) Drug preparations for treating sexual dysfunction
IL119017A0 (en) Bowl for hand mixing
TW422089U (en) Diaper for males
PL348107A1 (en) Therapy for improving cognition
EP1143948A3 (en) Liver-selective glucocorticoid antagonist for treating diabetes
HK1017899A1 (en) Process for the preparation of 17-esters of 9alpha,21-dihalo-pregnane-11beta,17alphadiol-20-ones
HU9702039D0 (en) Estrogen agonist/antagonists treatment of atheroscerosis
HK1028723A1 (en) Urinating aid for women
EP1119251A4 (en) METHOD FOR SCREENING ON ANALOG BONE THERAPY ACTIVE SUBSTANCES THAT CONTROL APOPTOSIS AND THEIR USE
HUP9901474A3 (en) Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy
SG106561A1 (en) Therapeutic agents for macromolecular structures
IL115225A0 (en) Preparations containing estrogen compounds for use in the treatment of osteoporosis
AU2003206424A1 (en) Sequential estrogen/progesterone antagonist combination for hormone replacement therapy
AUPP162298A0 (en) Process for expression of thyroid stimulating hormone receptor
GB9615350D0 (en) Hormone replacement therapy
AU2404399A (en) Process for expression of thyroid stimulating hormone receptor
TW360412U (en) Structure for pushing apparatus of rod & can body
KR0134822B1 (en) Vibrator for reducing apparatus of waste styropol
GB9800784D0 (en) Medical plasters for all